Sonic Healthcare (OTCMKTS:SKHHY) Stock Passes Below 200-Day Moving Average - Here's What Happened

Key Points

• Shares of Sonic Healthcare (OTCMKTS:SKHHY) slipped below their 200-day moving average of $15.06, trading as low as $14.79 and last at $14.89 on a volume of 76,277 shares.
• Citigroup downgraded Sonic from "hold" to a "strong sell", while MarketBeat shows a consensus rating of "Hold" and a consensus price target of $30.15, indicating a wide gap between analyst targets and the current ADR price.

Shares of Sonic Healthcare Ltd. Sponsored ADR (OTCMKTS:SKHHY - Get Free Report) passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $15.06 and traded as low as $14.79. Sonic Healthcare shares last traded at $14.89, with a volume of 76,277 shares traded.

Analysts Set New Price Targets

Separately, Citigroup cut Sonic Healthcare from a "hold" rating to a "strong sell" rating in a research note on Monday, January 26th. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, Sonic Healthcare has a consensus rating of "Hold" and a consensus price target of $30.15.

Sonic Healthcare Stock Down 1.0%

The stock's 50 day simple moving average is $15.84 and its two-hundred day simple moving average is $15.06. The company has a current ratio of 1.17, a quick ratio of 1.07 and a debt-to-equity ratio of 0.56.

About Sonic Healthcare

Sonic Healthcare OTCMKTS: SKHHY is a global provider of medical diagnostics services, specializing in pathology and radiology. Established in 1987 and headquartered in Sydney, Australia, the company has grown into one of the largest laboratory networks in the world. Its ordinary shares trade on the Australian Securities Exchange, and its American Depositary Receipts trade over the counter under the symbol SKHHY.

The company offers a broad range of clinical pathology services, including anatomic pathology, clinical chemistry, hematology, microbiology and molecular diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.